SLI
2.015,16
PKT
-7,49
PKT
-0,37
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.01.15 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
| 29.01.15 | Nestlé buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.01.15 | Roche buy | Deutsche Bank AG | |
| 29.01.15 | Roche overweight | Morgan Stanley | |
| 29.01.15 | UBS buy | Goldman Sachs Group Inc. | |
| 29.01.15 | UBS buy | Goldman Sachs Group Inc. | |
| 28.01.15 | Novartis neutral | Morgan Stanley | |
| 28.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 28.01.15 | Novartis Hold | Deutsche Bank AG | |
| 28.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.15 | Givaudan buy | Merrill Lynch & Co., Inc. | |
| 27.01.15 | Novartis Halten | Independent Research GmbH | |
| 27.01.15 | Nestlé Neutral | UBS AG | |
| 27.01.15 | UBS Hold | Jefferies & Company Inc. | |
| 27.01.15 | Nestlé Underperform | BNP PARIBAS | |
| 27.01.15 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.15 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 26.01.15 | Swiss Re Neutral | UBS AG | |
| 26.01.15 | Givaudan Neutral | Citigroup Corp. | |
| 26.01.15 | Holcim Neutral | BNP PARIBAS | |
| 26.01.15 | UBS Underweight | JP Morgan Chase & Co. | |
| 26.01.15 | UBS overweight | JP Morgan Chase & Co. | |
| 26.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 26.01.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.01.15 | ABB (Asea Brown Boveri) Neutral | Credit Suisse Group | |
| 26.01.15 | Givaudan Neutral | Nomura | |
| 26.01.15 | Swiss Re Underperform | BNP PARIBAS | |
| 23.01.15 | UBS buy | Citigroup Corp. | |
| 23.01.15 | UBS buy | Deutsche Bank AG | |
| 23.01.15 | UBS buy | Deutsche Bank AG | |
| 23.01.15 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 23.01.15 | UBS buy | Citigroup Corp. | |
| 23.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.15 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.01.15 | Roche Outperform | BNP PARIBAS | |
| 22.01.15 | Novartis Outperform | BNP PARIBAS | |
| 22.01.15 | Novartis buy | UBS AG | |
| 22.01.15 | Roche Neutral | UBS AG | |
| 22.01.15 | Swiss Re neutral | Barclays Capital | |
| 22.01.15 | Zurich Insurance Equal weight | Barclays Capital |